22 results on '"Rosenblat, Joshua D"'
Search Results
2. Association of SARS-CoV-2 infection with neurological impairments in pediatric population: A systematic review
3. Association of a low protein diet with depressive symptoms and poor health-related quality of life in CKD
4. Evaluating Anhedonia as a risk factor in suicidality: A meta-analysis
5. Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
6. The abuse liability of ketamine: A scoping review of preclinical and clinical studies
7. Pharmacogenomics of ketamine: A systematic review
8. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
9. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence
10. Registered clinical studies investigating psychedelic drugs for psychiatric disorders
11. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review
12. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review
13. Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence
14. Ecological momentary assessment of depressive symptoms using the mind.me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9)
15. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
16. Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin
17. Registered clinical trials investigating ketamine for psychiatric disorders
18. Association of SARS-CoV-2 infection with neurological impairments in pediatric population: A systematic review
19. Letter to the Editor: Clinical versus statistical significance of pharmacogenomic-guided antidepressant therapy: What's really being measured and marketed?
20. Letter to the editor: Inadequate evidence to support improved patient outcomes with combinatorial pharmacogenomics
21. Letter to the Editor: Clinical versus statistical significance of pharmacogenomic-guided antidepressant therapy: What's really being measured and marketed?
22. Pharmacogenomics of ketamine: A systematic review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.